XML 30 R19.htm IDEA: XBRL DOCUMENT v3.25.3
Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
Schedule of Marketable Securities

The following is a description of the valuation methodologies used for assets measured at fair value as of September 30, 2025 and December 31, 2024.

 

Marketable Securities: Valued using quoted prices in active markets for identical assets.

 

  

Quoted Prices in
Active Markets
for Identical
Assets or
Liabilities

(Level 1)

  

Quoted Prices

for Similar Assets

or Liabilities

in Active

Markets
(Level 2)

   Significant
Unobservable
Inputs (Level 3)
 
Marketable securities at September 30, 2025  $3,091,772   $       -   $         - 
                
Marketable securities at December 31, 2024  $8,345,081   $-   $- 
Contingent consideration payable at September 30, 2025            $9,380,000 
Contingent consideration payable at December 31, 2024            $0 
Schedule of Fair Value Hierarchy of the Valuation Inputs

 

       As of 
Description  Level  

September 30,

2025

  

December 31,

2024

 
Liabilities               
Warrant Liabilities   3   $         -   $- 
Derivative Liabilities   3   $2,896,000   $1,303,000 
Summary of Change in Fair Value of Warrant Liabilities

The following table sets forth a summary of the change in the fair value of the warrant liabilities that is measured at fair value on a recurring basis for the nine months ended September 30, 2025 and September 30, 2024, respectively:

 

Description  2025   2024 
Balance on December 31, 2024 and 2023  $   -   $867,000 
Issuance of warrants reported at fair value   -    - 
Change in fair value of warrant liabilities   -    7,094,000 
Reclassification of warrant liability to equity upon warrant modification   -    (7,961,000)
Balance on March 31,   -    - 
Issuance of warrants reported at fair value   -    21,992,000 
Change in fair value of warrant liabilities   -    (2,701,000)
Balance on June 30,   -    19,291,000 
Issuance of warrants reported at fair value   -    - 
Change in fair value of warrant liabilities   -    17,000 
Reclassification of warrant liability to equity upon warrant modification   -    (19,308,000)
Balance on September 30,  $-   $-
Summary of Change in Fair Value of Derivative Liabilities

The following table sets forth a summary of the change in the fair value of the derivative liabilities that is measured at fair value on a recurring basis for the nine months ended September 30, 2025 and September 30, 2024, respectively:

 

Description  2025   2024 
Balance on December 31, 2024 and 2023  $1,303,000   $61,000 
Issuance of derivatives reported at fair value   -    - 
Changes in fair value of derivative liabilities   (1,284,000)   (61,000)
Balance on March 31,   19,000    - 
Issuance of derivatives reported at fair value   -    854,000 
Change in fair value of derivative liabilities   (19,000)   72,000 
Balance on June 30,   -    926,000 
Issuance of derivatives reported at fair value   1,837,000    - 
Change in fair value of derivative liabilities   1,059,000    356,000 
Balance on September 30,  $2,896,000    1,282,000 
Schedule of Estimated Useful Lives of Property Plant and Equipment

The estimated useful lives for the current and comparative periods are as follows:

    

    Useful Life
    (in years)
Plant and equipment   5-12
Furniture and fixtures   5-10
Computer equipment & software   3-5
Leasehold Improvements   Shorter of the remaining lease or estimated useful life
Schedule of Estimated Useful Lives of Intangible Assets

Amortization is recognized on a straight-line basis over the estimated useful lives of intangible assets, other than goodwill, from the date that they are available for use. The estimated useful lives for the current and comparative periods are as follows:

    

    Useful Life
    (in years)
Patents and trademarks   12-17
Schedule of Condensed Consolidated Balance Sheet Information Related to Operating Lease

The Company’s operating leases are comprised of the 2021 Baltimore Lease and the 2024 Baltimore Lease on the Condensed Consolidated Balance Sheets. The information related to these leases is presented below:

 

   2024 Baltimore       2021 Baltimore   2024 Baltimore     
   As of September 30, 2025   As of December 31, 2024 
   2024 Baltimore       2021 Baltimore   2024 Baltimore     
Balance Sheet Location  Lease   Total   Lease   Lease   Total 
Operating Lease                         
Lease Right of Use  $       -   $   -   $       -   $10,579   $10,579 
Lease Payable, current   -    -    -    10,579    10,579 
Schedule of Lease Expense

The following provides details of the Company’s lease expense:

 

   2024 Baltimore       2021 Baltimore   2024 Baltimore     
  

For the Three Months Ended

September 30, 2025

  

For the Three Months Ended

September 30, 2024

 
   2024 Baltimore       2021 Baltimore   2024 Baltimore     
Lease Expenses  Lease   Total   Lease   Lease   Total 
Operating Leases                                               
Lease Costs  $-   $-    -   $8,100   $8,100 

 

   2024 Baltimore       2021 Baltimore   2024 Baltimore     
  

For the Nine Months Ended

September 30, 2025

  

For the Nine Months Ended

September 30, 2024

 
   2024 Baltimore       2021 Baltimore   2024 Baltimore     
Lease Expenses  Lease   Total   Lease   Lease   Total 
Operating Leases                         
Lease Costs  $10,800   $10,800   $18,672   $13,500   $32,172 
Schedule of Other Information Related to Leases

Other information as of September 30, 2025 related to leases is presented below:

 

   2024 Baltimore     
Other Information  Lease   Total 
Operating Leases          
Operating cash used  $10,800   $10,800 
Average remaining lease term   -    - 
Average discount rate   10.0%   10.0%
Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share

For the three and nine months ended September 30, 2025 and 2024, the following securities are excluded from the calculation of weighted average dilutive Common Stock because their inclusion would have been anti-dilutive.

 

   2025   2024   2025   2024 
   For the Three Months Ended
September 30,
   For the Nine Months Ended
September 30,
 
   2025   2024   2025   2024 
Stock Options   2,819    1,037    1,943    1,281 
Unvested Restricted Stock Units   484    488    484    754 
Warrants to purchase Common Stock   4,823,701    239,809    2,539,277    139,353 
Series C Convertible Preferred Stock Warrants   -    10    -    10 
Series D Convertible Preferred Stock   13    13    13    13 
Series F Convertible Preferred Stock   -    2,574,339    -    2,574,339 
Series F-1 Convertible Preferred Stock   -    2,780,837    -    2,780,837 
Series G Convertible Preferred Stock   2,657,135    4,928,414    2,598,701    4,187,775 
Series H Convertible Preferred Stock   1,799,603    -    1,799,603    - 
Series I Convertible Preferred Stock   665,030    -    665,030    - 
Total potentially dilutive shares   7,484,152    10,524,147    5,140,418    9,684,362